Developer docs
API playgroundTry for free, no card

Search company profiles

Instituto De Cancerología De Sucre

Full company profile

uuid004mw8z

Namestring
Instituto De Cancerología De Sucre
Legal namestring
Instituto de Cancerología de Sucre S.A.S.
Websiteurl
incans.com.co
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Instituto de Cancerología de Sucre S.A.S. ("Incans") is a private oncology institution founded in 2000 in Sincelejo, Sucre, Colombia, operating as a regional referral center for cancer care at the departmental level. The institution delivers a vertically integrated oncology platform that spans the full continuum of cancer diagnosis and treatment, including six clinical specialties (clinical oncology, oncohematology, gynecological oncology, urological oncology, mastology and soft tissue, orthopedic oncology) and ancillary service lines covering chemotherapy, radiotherapy, nuclear medicine, diagnostic imaging, clinical and pathology laboratories, hospitalization, pharmacy and compounding, and pre-transfusion management. Headcount is small (~20 employees) and the technology stack is described generically as "state-of-the-art" without disclosed platforms or proprietary systems, though a digital patient portal is hosted via a third-party telemedicine partner (Gotelemedicina).

The revenue model is professional-services based: Incans bills for consultations and procedures delivered on-site at its Cra. 22 #14-18 facility, with payment sourced from patients affiliated with Colombia's mandatory health insurance system (SGSSS) — specifically via Empresas Promotoras de Salud (EPS) and Instituciones Prestadoras de Servicios (IPS) — as well as direct private-pay patients. Go-to-market is sales-led and referral-driven rather than consumer-marketing-led, leveraging institutional affiliations with allied healthcare entities rather than direct acquisition. The institution maintains an informational and community-education presence across Facebook, Instagram, X, YouTube, and TikTok, and uses its website (incans.com.co) for service information and appointment scheduling. Pricing is not publicly disclosed and contracts under the Colombian system are administered through EPS/IPS arrangements.

Incans has no disclosed funding history, no parent company, no subsidiaries, and no executive team information in the public record. Ownership is private under Colombia's S.A.S. corporate form with no external investors identified. Over more than 20 years of continuous operation, the institution has progressively expanded its service network to consolidate its position as the primary oncology referral center in the Sucre department, addressing a structural gap in specialized cancer care access outside of Colombia's major metropolitan areas.

Short descriptiontext

Instituto de Cancerología de Sucre (Incans) is a private Colombian oncology institution founded in 2000 in Sincelejo, delivering comprehensive cancer care — diagnostics, chemotherapy, radiotherapy, and multiple surgical specialties — to patients across Sucre department via Colombia's SGSSS health system.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSincelejo, Colombia
HQ citystring
Sincelejo
HQ countrystring
Colombia
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology services, cancer treatment, chemotherapy, radiation therapy, nuclear medicine
Industry3 codes
1Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryYes
2Genitourinary Oncology
CodeHLAKAFAMPrimaryNo
3Hospital-Integrated Cancer Centers (Acute Oncology Programs)
CodeHLAFAAAMPrimaryNo
NAICS code1 code
  • Ambulatory Health Care Services621
SIC code2 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Oncology Healthcare Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Services Revenue
TypeProfessional Services
Description

Revenue generated from specialized oncology consultations, chemotherapy, radiotherapy, nuclear medicine, diagnostic imaging, clinical laboratory, pathology laboratory, hospitalization, and surgical procedures. Services are provided to patients covered by insurance (EPS), government health plans, and private pay patients.

incans.com.co
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Instituto De Cancerología De Sucre (Incans) is a private oncology healthcare institution founded in 2000 in Sincelejo, Sucre, Colombia. It provides comprehensive specialized oncology care including clinical oncology, oncohematology, gynecological oncology, urological oncology, mastology, orthopedic oncology, chemotherapy, radiation therapy, nuclear medicine, diagnostic imaging, clinical and pathology laboratory, hospitalization, pharmacy, and pre-transfusion management services. The institution serves as a regional referral center for cancer treatment within the Sucre department.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Instituto de Cancerología de Sucre S.A.S. is a private oncology institute established in 2000, offering a comprehensive cancer care ecosystem. The institution operates as a unified platform of specialized medical services including clinical oncology, oncohematology, gynecological oncology, urological oncology, mastology, orthopedic oncology, chemotherapy, radiation therapy, nuclear medicine, diagnostic imaging, clinical laboratory, pathology laboratory, hospitalization, pharmacy, and pre-transfusion management. All services are delivered through state-of-the-art technology and a highly specialized medical team, serving as a regional referral center in Sucre, Colombia.

Product and service1 record
1Oncología clínica (Clinical Oncology)
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Leading private hospital in Bogotá with an established oncology center. Comparable as a high-acuity Colombian provider offering multi-specialty oncology services including advanced diagnostics and treatment.

2Clínica Universidad de La Sabana
TypeDirect peer
Description

University-affiliated clinic near Bogotá offering oncology services. Comparable as a private Colombian provider of specialized cancer care, with academic/clinical research affiliation.

TypeDirect peer
Description

Colombia's national public cancer institute headquartered in Bogotá. Directly comparable as a specialized oncology center offering diagnosis, treatment, and research services, though operating at national scale and as a public reference center.

TypeBroad incumbent
Description

Major academic hospital in Bogotá with oncology services. Comparable as a comprehensive Colombian provider including cancer care, but with broader service portfolio beyond oncology.

5Centro Hospitalario Serena del Mar
TypeRegional player
Description

Modern hospital in Cartagena serving the Caribbean coast region. Comparable oncology offerings, but competes with Incans' catchment area for Caribbean-coast referrals from Sucre.

TypeDirect peer
Description

Bogotá-based private clinic with a recognized oncology unit. Comparable as a Colombian private institution delivering specialized cancer diagnosis and treatment.

TypeDirect peer
Description

High-complexity private hospital in Medellín with oncology services. Comparable as a Colombian tertiary provider offering integrated cancer care, though at larger scale and located in a major city.

TypeBroad incumbent
Description

Global leader in oncology care and research. Comparable as an oncology-focused institution, though operating at vastly larger scale and representing the upper benchmark of cancer center capabilities.

TypeDirect peer
Description

Major private hospital in Cali with a comprehensive oncology program. Comparable as a Colombian private provider offering integrated cancer care including chemo, radiotherapy, and surgical oncology.

10Centro de Tratamiento e Investigación sobre Cáncer (CTIC) Luis Carlos Sarmiento Angulo
TypeDirect peer
Description

Cancer treatment and research center in Bogotá offering comprehensive oncology services. Comparable as a dedicated cancer treatment center with similar scope of chemotherapy, radiotherapy, and diagnostics.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Instituto De Cancerología De Sucre

Oncology Healthcare Servicesincans.com.co

Instituto de Cancerología de Sucre (Incans) is a private Colombian oncology institution founded in 2000 in Sincelejo, delivering comprehensive cancer care — diagnostics, chemotherapy, radiotherapy, and multiple surgical specialties — to patients across Sucre department via Colombia's SGSSS health system.

What Instituto De Cancerología De Sucre does

Instituto de Cancerología de Sucre S.A.S. ("Incans") is a private oncology institution founded in 2000 in Sincelejo, Sucre, Colombia, operating as a regional referral center for cancer care at the departmental level. The institution delivers a vertically integrated oncology platform that spans the full continuum of cancer diagnosis and treatment, including six clinical specialties (clinical oncology, oncohematology, gynecological oncology, urological oncology, mastology and soft tissue, orthopedic oncology) and ancillary service lines covering chemotherapy, radiotherapy, nuclear medicine, diagnostic imaging, clinical and pathology laboratories, hospitalization, pharmacy and compounding, and pre-transfusion management. Headcount is small (~20 employees) and the technology stack is described generically as "state-of-the-art" without disclosed platforms or proprietary systems, though a digital patient portal is hosted via a third-party telemedicine partner (Gotelemedicina).

The revenue model is professional-services based: Incans bills for consultations and procedures delivered on-site at its Cra. 22 #14-18 facility, with payment sourced from patients affiliated with Colombia's mandatory health insurance system (SGSSS) — specifically via Empresas Promotoras de Salud (EPS) and Instituciones Prestadoras de Servicios (IPS) — as well as direct private-pay patients. Go-to-market is sales-led and referral-driven rather than consumer-marketing-led, leveraging institutional affiliations with allied healthcare entities rather than direct acquisition. The institution maintains an informational and community-education presence across Facebook, Instagram, X, YouTube, and TikTok, and uses its website (incans.com.co) for service information and appointment scheduling. Pricing is not publicly disclosed and contracts under the Colombian system are administered through EPS/IPS arrangements.

Incans has no disclosed funding history, no parent company, no subsidiaries, and no executive team information in the public record. Ownership is private under Colombia's S.A.S. corporate form with no external investors identified. Over more than 20 years of continuous operation, the institution has progressively expanded its service network to consolidate its position as the primary oncology referral center in the Sucre department, addressing a structural gap in specialized cancer care access outside of Colombia's major metropolitan areas.

Instituto De Cancerología De Sucre firmographics

Firmographics
Name
Instituto De Cancerología De Sucre
Legal name
Instituto de Cancerología de Sucre S.A.S.
Website
https://incans.com.co
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
Instituto de Cancerología de Sucre (Incans) is a private Colombian oncology institution founded in 2000 in Sincelejo, delivering comprehensive cancer care — diagnostics, chemotherapy, radiotherapy, and multiple surgical specialties — to patients across Sucre department via Colombia's SGSSS health system.
Ownership category
akta.pro rank

Instituto De Cancerología De Sucre industry classification

Industry
Product category
Oncology Healthcare Services
NAICS
Ambulatory Health Care Services (621)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
akta.pro secondary industries
Genitourinary Oncology (HLAKAFAM), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

  • Oncology services
  • Cancer treatment
  • Chemotherapy
  • Radiation therapy
  • Nuclear medicine

Where Instituto De Cancerología De Sucre is headquartered

Location

Headquarters

HQ city
Sincelejo
HQ country
Colombia
HQ region
Latin America

Offices1 record

Markets served

Instituto De Cancerología De Sucre business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Medical Services Revenue: Revenue generated from specialized oncology consultations, chemotherapy, radiotherapy, nuclear medicine, diagnostic imaging, clinical laboratory, pathology laboratory, hospitalization, and surgical procedures. Services are provided to patients covered by insurance (EPS), government health plans, and private pay patients.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Instituto De Cancerología De Sucre product offering

Product offering

Core offering

Instituto De Cancerología De Sucre (Incans) is a private oncology healthcare institution founded in 2000 in Sincelejo, Sucre, Colombia. It provides comprehensive specialized oncology care including clinical oncology, oncohematology, gynecological oncology, urological oncology, mastology, orthopedic oncology, chemotherapy, radiation therapy, nuclear medicine, diagnostic imaging, clinical and pathology laboratory, hospitalization, pharmacy, and pre-transfusion management services. The institution serves as a regional referral center for cancer treatment within the Sucre department.

Product overview

Instituto de Cancerología de Sucre S.A.S. is a private oncology institute established in 2000, offering a comprehensive cancer care ecosystem. The institution operates as a unified platform of specialized medical services including clinical oncology, oncohematology, gynecological oncology, urological oncology, mastology, orthopedic oncology, chemotherapy, radiation therapy, nuclear medicine, diagnostic imaging, clinical laboratory, pathology laboratory, hospitalization, pharmacy, and pre-transfusion management. All services are delivered through state-of-the-art technology and a highly specialized medical team, serving as a regional referral center in Sucre, Colombia.

Differentiator

Problem solved

Functional benefit

Products and services

  • Oncología clínica (Clinical Oncology)

Companies that use Instituto De Cancerología De Sucre

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Instituto De Cancerología De Sucre technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Instituto De Cancerología De Sucre partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Instituto De Cancerología De Sucre competitors and assessment

Company assessment

Direct peers

  • Fundación Santa Fe de Bogotá: Leading private hospital in Bogotá with an established oncology center. Comparable as a high-acuity Colombian provider offering multi-specialty oncology services including advanced diagnostics and treatment.
  • Clínica Universidad de La Sabana: University-affiliated clinic near Bogotá offering oncology services. Comparable as a private Colombian provider of specialized cancer care, with academic/clinical research affiliation.
  • Instituto Nacional de Cancerología: Colombia's national public cancer institute headquartered in Bogotá. Directly comparable as a specialized oncology center offering diagnosis, treatment, and research services, though operating at national scale and as a public reference center.
  • Clínica del Country: Bogotá-based private clinic with a recognized oncology unit. Comparable as a Colombian private institution delivering specialized cancer diagnosis and treatment.
  • Hospital Pablo Tobón Uribe: High-complexity private hospital in Medellín with oncology services. Comparable as a Colombian tertiary provider offering integrated cancer care, though at larger scale and located in a major city.
  • Centro Médico Imbanaco: Major private hospital in Cali with a comprehensive oncology program. Comparable as a Colombian private provider offering integrated cancer care including chemo, radiotherapy, and surgical oncology.
  • Centro de Tratamiento e Investigación sobre Cáncer (CTIC) Luis Carlos Sarmiento Angulo: Cancer treatment and research center in Bogotá offering comprehensive oncology services. Comparable as a dedicated cancer treatment center with similar scope of chemotherapy, radiotherapy, and diagnostics.

Broad incumbents

  • Hospital Universitario San Ignacio: Major academic hospital in Bogotá with oncology services. Comparable as a comprehensive Colombian provider including cancer care, but with broader service portfolio beyond oncology.
  • MD Anderson Cancer Center: Global leader in oncology care and research. Comparable as an oncology-focused institution, though operating at vastly larger scale and representing the upper benchmark of cancer center capabilities.

Regional players

  • Centro Hospitalario Serena del Mar: Modern hospital in Cartagena serving the Caribbean coast region. Comparable oncology offerings, but competes with Incans' catchment area for Caribbean-coast referrals from Sucre.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Instituto De Cancerología De Sucre social profiles

Digital presence

Instituto De Cancerología De Sucre financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Instituto De Cancerología De Sucre leadership team

Management profile

Number of profiles

Instituto De Cancerología De Sucre funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Instituto De Cancerología De Sucre M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto De Cancerología De Sucre

What does Instituto De Cancerología De Sucre do?

Instituto De Cancerología De Sucre (Incans) is a private oncology healthcare institution founded in 2000 in Sincelejo, Sucre, Colombia. It provides comprehensive specialized oncology care including clinical oncology, oncohematology, gynecological oncology, urological oncology, mastology, orthopedic oncology, chemotherapy, radiation therapy, nuclear medicine, diagnostic imaging, clinical and pathology laboratory, hospitalization, pharmacy, and pre-transfusion management services. The institution serves as a regional referral center for cancer treatment within the Sucre department.

Is Instituto De Cancerología De Sucre a public or private company?

Instituto De Cancerología De Sucre is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Instituto De Cancerología De Sucre founded?

Instituto De Cancerología De Sucre was founded in 2000. It employs 11 to 50 people.

Where is Instituto De Cancerología De Sucre based?

Instituto De Cancerología De Sucre is headquartered in Sincelejo, Colombia, in the Latin America region.

How does Instituto De Cancerología De Sucre make money?

One revenue line is on record: medical Services Revenue.

Who are Instituto De Cancerología De Sucre's main competitors?

Direct peers on record are Fundación Santa Fe de Bogotá, Clínica Universidad de La Sabana, Instituto Nacional de Cancerología, Clínica del Country, Hospital Pablo Tobón Uribe, Centro Médico Imbanaco and Centro de Tratamiento e Investigación sobre Cáncer (CTIC) Luis Carlos Sarmiento Angulo. Broad incumbents are Hospital Universitario San Ignacio and MD Anderson Cancer Center. Centro Hospitalario Serena del Mar is listed as a regional player.

Does Instituto De Cancerología De Sucre have an API?

No public API is recorded for Instituto De Cancerología De Sucre.

What industry is Instituto De Cancerología De Sucre in?

Instituto De Cancerología De Sucre's product category is Oncology Healthcare Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAKAFAM, Genitourinary Oncology. Its NAICS code is 621 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales